This innovative method promoted continuous arginine supplementation in murine colorectal carcinoma tumors, leading to increased CD8+ T cell infiltration and synergistic anti-tumor effects when combined with anti-PD-L1 treatment[159]. The gene discussed is CD274; the disease is neoplasm.